Randomized Controlled Trial
Copyright ©The Author(s) 2023.
World J Clin Cases. Jun 6, 2023; 11(16): 3802-3812
Published online Jun 6, 2023. doi: 10.12998/wjcc.v11.i16.3802
Table 1 Demographic data of patients included in the two groups

CR-PT group (31)
AP-PT group (34)
P value
Sex (male:female) 19:1218:160.5
Height (cm)168.29 ± 7.99167.53 ± 8.180.71
Weight (kg)66 (62, 75)69 (60, 80)0.17
BMI (kg/cm2)25.3 (22.63, 28.04)27.25 (23.19, 33.35)0.15
Age55 (41, 65)58 (38, 66)0.5
Surgical segment
L1/L2020.57
L2/L310
L3/L413
L4/L52019
L5/S1910
Laterality (left:right)18:1312:220.07
Pain duration (mo)6 (1, 24)6 (2, 24)0.64
Table 2 Clinical outcomes of the two groups

CR-PT group (31)
AP-PT group (33)
P value
Number of fluoroscopies12 (11, 14)16 (12, 23)0.002
Puncture duration20.42 ± 5.7825.06 ± 5.460.002
Surgery duration115 (107, 124)123 (92, 148.5)0.173
VAS score during puncturing3 (2, 4)3 (3, 4)0.021
Puncture success rate (34 participants included for AP-PT group)100%97.06%1
Table 3 Clinical outcomes of the two groups in the L5/S1 segment

CR-PT subgroup (9)
AP-PT subgroup (9)
P value
Number of fluoroscopies11.56 ± 0.8825.22 ± 5.330
Puncture duration13.89 ± 1.4528.89 ± 3.760
Surgery duration105 (99.5, 120)149 (125, 157.5)0
VAS score during puncturing2.11 ± 0.933.89 ± 0.60